Literature DB >> 25671443

The rosacea patient journey: a novel approach to conceptualizing patient experiences.

Sandy Kuo, Karen E Huang1, Scott A Davis, Steven R Feldman.   

Abstract

The motivation for rosacea patients to seek and adhere to treatment is not well characterized. A patient journey is a map of the steps a patient takes as he/she progresses through different segments of the disease from diagnosis to management, including all the influences that can push him/her toward or away from certain decisions. We sought to examine each step of the rosacea patient journey to better understand key patient care boundaries faced by rosacea patients. A PubMed search of articles indexed for MEDLINE as well as a search of the National Rosacea Society Web site (http://www.rosacea.org) were conducted to identify articles and materials that quantitatively or qualitatively described rosacea patient experiences. Current literature pertaining to the rosacea patient journey was summarized. The rosacea patient journey is discussed. It is a useful tool to gain insight on patient experiences. Better understanding of the patient perspective by dermatologists can lead to better patient adherence to treatment and thus improved quality of life and satisfaction.

Entities:  

Mesh:

Year:  2015        PMID: 25671443

Source DB:  PubMed          Journal:  Cutis        ISSN: 0011-4162


  3 in total

1.  How to Optimize Rosacea Treatment for Better Patient Outcomes: An Opinion Piece.

Authors:  Martin Schaller; Jerry Tan; Guy Webster
Journal:  J Clin Aesthet Dermatol       Date:  2022-07

2.  The feasibility and potential use of case-tracked client journeys in primary healthcare: a pilot study.

Authors:  Elsa Barton; Toby Freeman; Fran Baum; Sara Javanparast; Angela Lawless
Journal:  BMJ Open       Date:  2019-06-01       Impact factor: 2.692

3.  Sex-Specific Patient Journeys in Early Parkinson's Disease in the Netherlands.

Authors:  Floris Pieter Vlaanderen; Yvonne de Man; Jesse H Krijthe; Marit A C Tanke; A S Groenewoud; Patrick P T Jeurissen; Sabine Oertelt-Prigione; Marten Munneke; Bastiaan R Bloem; Marjan J Meinders
Journal:  Front Neurol       Date:  2019-07-30       Impact factor: 4.003

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.